“MIT” is often used as shorthand for mitragynine, but it is not a complete product specification. Before designing a kratom or mitragynine label, establish exactly what the product is and how the responsible business has verified that description. Do not let a shorthand name obscure important differences between products.
Keep product identity precise
The FDA's kratom information distinguishes the plant and its constituents, including mitragynine and 7-hydroxymitragynine, and describes the agency's safety concerns. FDA has not approved kratom to treat a medical condition. A packaging article or laboratory document should not be presented as an agency approval or a guarantee of safety.
Have the responsible reviewer confirm the product category, destination, eligibility, and permitted claims. A pack for ordinary leaf material should not be reused for a different extract simply by changing the front-panel name.
Connect the label to the product record
Build the brief around an approved product identity, ingredient information where applicable, quantity, responsible-business details, and the information that changes between batches. Record who supplies each field and who verifies it. Avoid copying potency or ingredient statements from visual references.
If a certificate of analysis is part of the supporting record, match it to the correct product and batch. Review what was actually tested and what the report establishes. A broad “lab tested” graphic is less informative than a clear connection to the relevant evidence.
Choose the physical format deliberately
Compare containers using the product's actual form and quantity. Check label area, closure fit, filling clearance, and how the pack will be handled. Obtain the documentation required for any package-performance claim. A familiar zipper or cap design is not itself proof that the finished configuration meets a particular standard.
Approve readable, consistent artwork
Place the approved product description prominently and keep changing fields separate from decoration. Review the assembled unit at actual size, including any carton or sleeve. Confirm that the front, information panel, and supporting records describe the same product.
For a terminology overview, see kratom and 7-OH: the distinction. Keep medical claims and product-eligibility decisions with qualified reviewers; the packaging brief should reflect their verified inputs.
Find related packaging guides by market and product, or discuss your packaging brief with Mylarmen.